Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,313 | 4 | 69.7% |
| Travel and Lodging | $2,293 | 7 | 13.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,995 | 1 | 11.3% |
| Food and Beverage | $1,066 | 7 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $10,572 | 7 | $0 (2024) |
| Relypsa, Inc. | $3,660 | 7 | $0 (2019) |
| Corcept Therapeutics | $2,119 | 2 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,291 | 2 | $0 (2022) |
| NATUS MEDICAL INCORPORATED | $24.25 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,692 | 9 | Novo Nordisk Inc ($10,572) |
| 2022 | $1,200 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($1,200) |
| 2019 | $3,751 | 8 | Relypsa, Inc. ($3,660) |
| 2017 | $24.25 | 1 | NATUS MEDICAL INCORPORATED ($24.25) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,995.00 | General |
| Category: Endocrinology | ||||||
| 09/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $124.44 | General |
| Category: Endocrinology | ||||||
| 08/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.02 | General |
| 06/24/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $8,212.50 | General |
| 06/24/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $716.72 | General |
| 06/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $467.78 | General |
| 06/24/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $357.76 | General |
| 06/24/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $347.33 | General |
| 06/23/2024 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| 02/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: Cardio-renal | ||||||
| 07/19/2019 | Relypsa, Inc. | Veltassa (Drug) | Consulting Fee | Cash or cash equivalent | $2,450.00 | General |
| Category: Hyperkalemia | ||||||
| 07/12/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | Cash or cash equivalent | $213.70 | General |
| Category: Hyperkalemia | ||||||
| 07/12/2019 | Relypsa, Inc. | Veltassa (Drug) | Travel and Lodging | In-kind items and services | $33.38 | General |
| Category: Hyperkalemia | ||||||
| 07/11/2019 | Relypsa, Inc. | Veltassa (Drug) | Travel and Lodging | In-kind items and services | $422.60 | General |
| Category: Hyperkalemia | ||||||
| 07/11/2019 | Relypsa, Inc. | Veltassa (Drug) | Travel and Lodging | In-kind items and services | $311.12 | General |
| Category: Hyperkalemia | ||||||
| 07/11/2019 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Hyperkalemia | ||||||
| 07/11/2019 | Relypsa, Inc. | Veltassa (Drug) | Travel and Lodging | In-kind items and services | $104.30 | General |
| Category: Hyperkalemia | ||||||
| 03/21/2019 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered (Drug) | Food and Beverage | In-kind items and services | $90.67 | General |
| 02/01/2017 | NATUS MEDICAL INCORPORATED | — | Food and Beverage | Cash or cash equivalent | $24.25 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 147 | 198 | $71,661 | $14,476 |
| 2022 | 4 | 132 | 172 | $55,188 | $12,107 |
| 2021 | 6 | 142 | 188 | $54,615 | $12,794 |
| 2020 | 3 | 85 | 121 | $35,597 | $6,856 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 104 | 155 | $49,290 | $10,478 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 28 | 28 | $13,776 | $2,614 | 19.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $8,595 | $1,384 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 74 | 105 | $33,390 | $6,748 | 20.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 26 | $8,598 | $2,655 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 19 | 19 | $9,348 | $1,520 | 16.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 22 | $3,852 | $1,185 | 30.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 75 | 105 | $33,390 | $7,017 | 21.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 17 | 17 | $8,364 | $1,601 | 19.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 28 | $4,732 | $1,544 | 32.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $3,852 | $1,249 | 32.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 13 | 13 | $3,055 | $998.79 | 32.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 11 | 13 | $1,222 | $383.89 | 31.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 58 | 90 | $26,888 | $4,838 | 18.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 19 | $3,211 | $1,014 | 31.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 12 | 12 | $5,498 | $1,003 | 18.2% |
About Dr. James Luther, MD
Dr. James Luther, MD is a Nephrology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295882165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Luther, MD has received a total of $17,667 in payments from pharmaceutical and medical device companies, with $12,692 received in 2024. These payments were reported across 19 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($12,313).
As a Medicare-enrolled provider, Luther has provided services to 506 Medicare beneficiaries, totaling 679 services with total Medicare billing of $46,233. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Nashville, TN
- Active Since 01/04/2007
- Last Updated 03/21/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1295882165
Products in Payments
- Veltassa (Drug) $3,660
- Korlym (Drug) $2,119
- Kerendia (Drug) $1,200
- Non-Covered (Drug) $90.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Nashville
Dr. Jamie Dwyer, M.d, M.D
Nephrology — Payments: $549,974
Talat Ikizler, Md, MD
Nephrology — Payments: $240,153
Julia Lewis, Md, MD
Nephrology — Payments: $126,571
Dr. Volker Haase, M.d, M.D
Nephrology — Payments: $125,972
Alfred George, Md, MD
Nephrology — Payments: $51,836
Dr. Thomas Golper, Md, MD
Nephrology — Payments: $33,757